Drug Profile
Emtricitabine/tenofovir disoproxil fumarate + nevirapine - Mylan Pharmaceuticals
Alternative Names: Tenofovir disoproxil fumarate/emtricitabine + nevirapine - Mylan PharmaceuticalsLatest Information Update: 03 Dec 2018
Price :
$50
*
At a glance
- Originator Mylan Pharmaceuticals
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Cyclopropanes; Deoxyribonucleosides; Phosphonic acids; Purines; Pyridines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action DNA polymerase beta inhibitors; DNA polymerase gamma inhibitors; DNA polymerase I inhibitors; DNA polymerase II inhibitors; HIV reverse transcriptase inhibitors; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Submission Withdrawal HIV-1 infections
Most Recent Events
- 03 Dec 2018 Chemical structure information added